Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | -.--% | +240.87% |
Sales 2022 | 30.06M 41.33M | Sales 2023 | 58.88M 80.94M | Capitalization | 1.11B 1.52B |
---|---|---|---|---|---|
Net income 2022 | -57M -78.36M | Net income 2023 | -32M -43.99M | EV / Sales 2022 | 3.79 x |
Net cash position 2022 | 223M 307M | Net cash position 2023 | 317M 436M | EV / Sales 2023 | 13.4 x |
P/E ratio 2022 |
-4.25
x | P/E ratio 2023 |
-29.6
x | Employees | 142 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.04% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
3 months | +78.59% | ||
6 months | +243.76% | ||
Current year | +240.87% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +10.59% | - |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+16.42% | 122B | |
+19.02% | 113B | |
+2.79% | 22.66B | |
-11.63% | 16.68B | |
-16.33% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- ALPN Stock